brain lipid Search Results


brain polar lipid extract  (Avanti Polar)
97
Avanti Polar brain polar lipid extract
Brain Polar Lipid Extract, supplied by Avanti Polar, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brain polar lipid extract/product/Avanti Polar
Average 97 stars, based on 1 article reviews
brain polar lipid extract - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier
fabp markers  (Shanghai Korain Biotech Co Ltd)
92
Shanghai Korain Biotech Co Ltd fabp markers
Fabp Markers, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fabp markers/product/Shanghai Korain Biotech Co Ltd
Average 92 stars, based on 1 article reviews
fabp markers - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier
total lipid brain extract  (Avanti Polar)
96
Avanti Polar total lipid brain extract
Total Lipid Brain Extract, supplied by Avanti Polar, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/total lipid brain extract/product/Avanti Polar
Average 96 stars, based on 1 article reviews
total lipid brain extract - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
fabp7  (Proteintech)
93
Proteintech fabp7
Fabp7, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fabp7/product/Proteintech
Average 93 stars, based on 1 article reviews
fabp7 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
fabp7 polyclonal antibody  (Proteintech)
92
Proteintech fabp7 polyclonal antibody
Expression of <t>FABP7</t> in clear cell renal cell carcinoma (ccRCC) tissues compared with normal renal and non-ccRCC tissues (20´). A, C, E, G, and I) The illustration depicts histomorphology features with H&E staining of normal renal tissue, ccRCC, papillary RCC (pRCC), chromophobe RCC (chRCC), and rare subtypes RCC (rRCC). B, D, F, H, and J) The expression of FABP7 in normal renal tissue, ccRCC, pRCC, chRCC, and rRCC. B) The weak membranous and cytoplasmic staining of FABP7 in normal renal tubes. D) In ccRCC, FABP7 is expressed differently between low nuclear grade (low expression) and high nuclear grade (high expression). F, H, and J) FABP7 showed negative staining in non-ccRCC groups, including pRCC, chRCC, and rRCC.
Fabp7 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fabp7 polyclonal antibody/product/Proteintech
Average 92 stars, based on 1 article reviews
fabp7 polyclonal antibody - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier
peptide pkkppqrlewklntgrte  (ProSci Incorporated)
90
ProSci Incorporated peptide pkkppqrlewklntgrte
Expression of <t>FABP7</t> in clear cell renal cell carcinoma (ccRCC) tissues compared with normal renal and non-ccRCC tissues (20´). A, C, E, G, and I) The illustration depicts histomorphology features with H&E staining of normal renal tissue, ccRCC, papillary RCC (pRCC), chromophobe RCC (chRCC), and rare subtypes RCC (rRCC). B, D, F, H, and J) The expression of FABP7 in normal renal tissue, ccRCC, pRCC, chRCC, and rRCC. B) The weak membranous and cytoplasmic staining of FABP7 in normal renal tubes. D) In ccRCC, FABP7 is expressed differently between low nuclear grade (low expression) and high nuclear grade (high expression). F, H, and J) FABP7 showed negative staining in non-ccRCC groups, including pRCC, chRCC, and rRCC.
Peptide Pkkppqrlewklntgrte, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peptide pkkppqrlewklntgrte/product/ProSci Incorporated
Average 90 stars, based on 1 article reviews
peptide pkkppqrlewklntgrte - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
soy polar lipid mixture  (Avanti Inc)
90
Avanti Inc soy polar lipid mixture
Expression of <t>FABP7</t> in clear cell renal cell carcinoma (ccRCC) tissues compared with normal renal and non-ccRCC tissues (20´). A, C, E, G, and I) The illustration depicts histomorphology features with H&E staining of normal renal tissue, ccRCC, papillary RCC (pRCC), chromophobe RCC (chRCC), and rare subtypes RCC (rRCC). B, D, F, H, and J) The expression of FABP7 in normal renal tissue, ccRCC, pRCC, chRCC, and rRCC. B) The weak membranous and cytoplasmic staining of FABP7 in normal renal tubes. D) In ccRCC, FABP7 is expressed differently between low nuclear grade (low expression) and high nuclear grade (high expression). F, H, and J) FABP7 showed negative staining in non-ccRCC groups, including pRCC, chRCC, and rRCC.
Soy Polar Lipid Mixture, supplied by Avanti Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/soy polar lipid mixture/product/Avanti Inc
Average 90 stars, based on 1 article reviews
soy polar lipid mixture - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
porcine polar brain lipid extract (pble) solution (16.0 mg of pble + 8.0 mg of cholesterol dissolved in 600.0 μl of n -dodecane)  (Merck & Co)
90
Merck & Co porcine polar brain lipid extract (pble) solution (16.0 mg of pble + 8.0 mg of cholesterol dissolved in 600.0 μl of n -dodecane)
Expression of <t>FABP7</t> in clear cell renal cell carcinoma (ccRCC) tissues compared with normal renal and non-ccRCC tissues (20´). A, C, E, G, and I) The illustration depicts histomorphology features with H&E staining of normal renal tissue, ccRCC, papillary RCC (pRCC), chromophobe RCC (chRCC), and rare subtypes RCC (rRCC). B, D, F, H, and J) The expression of FABP7 in normal renal tissue, ccRCC, pRCC, chRCC, and rRCC. B) The weak membranous and cytoplasmic staining of FABP7 in normal renal tubes. D) In ccRCC, FABP7 is expressed differently between low nuclear grade (low expression) and high nuclear grade (high expression). F, H, and J) FABP7 showed negative staining in non-ccRCC groups, including pRCC, chRCC, and rRCC.
Porcine Polar Brain Lipid Extract (Pble) Solution (16.0 Mg Of Pble + 8.0 Mg Of Cholesterol Dissolved In 600.0 μl Of N Dodecane), supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/porcine polar brain lipid extract (pble) solution (16.0 mg of pble + 8.0 mg of cholesterol dissolved in 600.0 μl of n -dodecane)/product/Merck & Co
Average 90 stars, based on 1 article reviews
porcine polar brain lipid extract (pble) solution (16.0 mg of pble + 8.0 mg of cholesterol dissolved in 600.0 μl of n -dodecane) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
brain polar lipids  (Merck & Co)
90
Merck & Co brain polar lipids
Expression of <t>FABP7</t> in clear cell renal cell carcinoma (ccRCC) tissues compared with normal renal and non-ccRCC tissues (20´). A, C, E, G, and I) The illustration depicts histomorphology features with H&E staining of normal renal tissue, ccRCC, papillary RCC (pRCC), chromophobe RCC (chRCC), and rare subtypes RCC (rRCC). B, D, F, H, and J) The expression of FABP7 in normal renal tissue, ccRCC, pRCC, chRCC, and rRCC. B) The weak membranous and cytoplasmic staining of FABP7 in normal renal tubes. D) In ccRCC, FABP7 is expressed differently between low nuclear grade (low expression) and high nuclear grade (high expression). F, H, and J) FABP7 showed negative staining in non-ccRCC groups, including pRCC, chRCC, and rRCC.
Brain Polar Lipids, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brain polar lipids/product/Merck & Co
Average 90 stars, based on 1 article reviews
brain polar lipids - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
gel filtration profile of 5ht3ar reconstituted in saposins and brain polar lipids (i.e., salipro)  (Salipro Biotech AB)
90
Salipro Biotech AB gel filtration profile of 5ht3ar reconstituted in saposins and brain polar lipids (i.e., salipro)
Expression of <t>FABP7</t> in clear cell renal cell carcinoma (ccRCC) tissues compared with normal renal and non-ccRCC tissues (20´). A, C, E, G, and I) The illustration depicts histomorphology features with H&E staining of normal renal tissue, ccRCC, papillary RCC (pRCC), chromophobe RCC (chRCC), and rare subtypes RCC (rRCC). B, D, F, H, and J) The expression of FABP7 in normal renal tissue, ccRCC, pRCC, chRCC, and rRCC. B) The weak membranous and cytoplasmic staining of FABP7 in normal renal tubes. D) In ccRCC, FABP7 is expressed differently between low nuclear grade (low expression) and high nuclear grade (high expression). F, H, and J) FABP7 showed negative staining in non-ccRCC groups, including pRCC, chRCC, and rRCC.
Gel Filtration Profile Of 5ht3ar Reconstituted In Saposins And Brain Polar Lipids (I.E., Salipro), supplied by Salipro Biotech AB, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gel filtration profile of 5ht3ar reconstituted in saposins and brain polar lipids (i.e., salipro)/product/Salipro Biotech AB
Average 90 stars, based on 1 article reviews
gel filtration profile of 5ht3ar reconstituted in saposins and brain polar lipids (i.e., salipro) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
antibody to brain lipid-binding protein (blbp)  (Wadiche labs)
90
Wadiche labs antibody to brain lipid-binding protein (blbp)
Expression of <t>FABP7</t> in clear cell renal cell carcinoma (ccRCC) tissues compared with normal renal and non-ccRCC tissues (20´). A, C, E, G, and I) The illustration depicts histomorphology features with H&E staining of normal renal tissue, ccRCC, papillary RCC (pRCC), chromophobe RCC (chRCC), and rare subtypes RCC (rRCC). B, D, F, H, and J) The expression of FABP7 in normal renal tissue, ccRCC, pRCC, chRCC, and rRCC. B) The weak membranous and cytoplasmic staining of FABP7 in normal renal tubes. D) In ccRCC, FABP7 is expressed differently between low nuclear grade (low expression) and high nuclear grade (high expression). F, H, and J) FABP7 showed negative staining in non-ccRCC groups, including pRCC, chRCC, and rRCC.
Antibody To Brain Lipid Binding Protein (Blbp), supplied by Wadiche labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibody to brain lipid-binding protein (blbp)/product/Wadiche labs
Average 90 stars, based on 1 article reviews
antibody to brain lipid-binding protein (blbp) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
lipid standards 3-sn-phosphatidylethanolamine (from bovine brain, ≥98)  (Merck KGaA)
90
Merck KGaA lipid standards 3-sn-phosphatidylethanolamine (from bovine brain, ≥98)
Expression of <t>FABP7</t> in clear cell renal cell carcinoma (ccRCC) tissues compared with normal renal and non-ccRCC tissues (20´). A, C, E, G, and I) The illustration depicts histomorphology features with H&E staining of normal renal tissue, ccRCC, papillary RCC (pRCC), chromophobe RCC (chRCC), and rare subtypes RCC (rRCC). B, D, F, H, and J) The expression of FABP7 in normal renal tissue, ccRCC, pRCC, chRCC, and rRCC. B) The weak membranous and cytoplasmic staining of FABP7 in normal renal tubes. D) In ccRCC, FABP7 is expressed differently between low nuclear grade (low expression) and high nuclear grade (high expression). F, H, and J) FABP7 showed negative staining in non-ccRCC groups, including pRCC, chRCC, and rRCC.
Lipid Standards 3 Sn Phosphatidylethanolamine (From Bovine Brain, ≥98), supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lipid standards 3-sn-phosphatidylethanolamine (from bovine brain, ≥98)/product/Merck KGaA
Average 90 stars, based on 1 article reviews
lipid standards 3-sn-phosphatidylethanolamine (from bovine brain, ≥98) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Expression of FABP7 in clear cell renal cell carcinoma (ccRCC) tissues compared with normal renal and non-ccRCC tissues (20´). A, C, E, G, and I) The illustration depicts histomorphology features with H&E staining of normal renal tissue, ccRCC, papillary RCC (pRCC), chromophobe RCC (chRCC), and rare subtypes RCC (rRCC). B, D, F, H, and J) The expression of FABP7 in normal renal tissue, ccRCC, pRCC, chRCC, and rRCC. B) The weak membranous and cytoplasmic staining of FABP7 in normal renal tubes. D) In ccRCC, FABP7 is expressed differently between low nuclear grade (low expression) and high nuclear grade (high expression). F, H, and J) FABP7 showed negative staining in non-ccRCC groups, including pRCC, chRCC, and rRCC.

Journal: In Vivo

Article Title: FABP7: A Potential Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma

doi: 10.21873/invivo.13773

Figure Lengend Snippet: Expression of FABP7 in clear cell renal cell carcinoma (ccRCC) tissues compared with normal renal and non-ccRCC tissues (20´). A, C, E, G, and I) The illustration depicts histomorphology features with H&E staining of normal renal tissue, ccRCC, papillary RCC (pRCC), chromophobe RCC (chRCC), and rare subtypes RCC (rRCC). B, D, F, H, and J) The expression of FABP7 in normal renal tissue, ccRCC, pRCC, chRCC, and rRCC. B) The weak membranous and cytoplasmic staining of FABP7 in normal renal tubes. D) In ccRCC, FABP7 is expressed differently between low nuclear grade (low expression) and high nuclear grade (high expression). F, H, and J) FABP7 showed negative staining in non-ccRCC groups, including pRCC, chRCC, and rRCC.

Article Snippet: The samples were stained with a FABP7 polyclonal antibody (dilution 1:100, Proteintech, Chicago, IL, USA).

Techniques: Expressing, Staining, Negative Staining

The gene distribution and the receiver operating characteristic curve of FABP7 expression between clear cell renal cell carcinoma (ccRCC) and non-ccRCC. A) The box plot diagram of FABP7 protein expression comparing ccRCC and non-ccRCC. The x-axis represents the groups of RCC, and the y-axis represents the gene expression values based on the immunohistology score (H-score). FABP7 increased in ccRCC groups compared with non-ccRCC. B) In the ROC curve and AUC analysis of FABP7 expression, the AUC value was moderate, 0.71. C) The box plots of FABP7 expression in three common subtypes of RCC compared with normal tissues. The x-axis represents the three common subtypes of RCC, including ccRCC, pRCC, and chRCC. The y-axis represents the FABBP7 expression based on log2 values. Expression of FABP7 mRNA in 523 ccRCC compared to 100 normal tissues was statistically significant. In pRCC, there is minimal FABP7 mRNA expression, although lower than that observed in ccRCC. There is no expression of FABP7 mRNA in chRCC. *p<0.05.

Journal: In Vivo

Article Title: FABP7: A Potential Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma

doi: 10.21873/invivo.13773

Figure Lengend Snippet: The gene distribution and the receiver operating characteristic curve of FABP7 expression between clear cell renal cell carcinoma (ccRCC) and non-ccRCC. A) The box plot diagram of FABP7 protein expression comparing ccRCC and non-ccRCC. The x-axis represents the groups of RCC, and the y-axis represents the gene expression values based on the immunohistology score (H-score). FABP7 increased in ccRCC groups compared with non-ccRCC. B) In the ROC curve and AUC analysis of FABP7 expression, the AUC value was moderate, 0.71. C) The box plots of FABP7 expression in three common subtypes of RCC compared with normal tissues. The x-axis represents the three common subtypes of RCC, including ccRCC, pRCC, and chRCC. The y-axis represents the FABBP7 expression based on log2 values. Expression of FABP7 mRNA in 523 ccRCC compared to 100 normal tissues was statistically significant. In pRCC, there is minimal FABP7 mRNA expression, although lower than that observed in ccRCC. There is no expression of FABP7 mRNA in chRCC. *p<0.05.

Article Snippet: The samples were stained with a FABP7 polyclonal antibody (dilution 1:100, Proteintech, Chicago, IL, USA).

Techniques: Expressing, Gene Expression

The violin plots of the correlation between FABP7 and the pathological stage of renal cell carcinoma (RCC) in each subtype. A) ccRCC; the level of FABP7 expression was closely associated with the advanced pathological stages of clear cell RCC (ccRCC). B and C) pRCC and chRCC; the expression of FABP7 was not statistically significant. The x-axis represents the FABP7 expression; the y-axis represents the pathological stages. F Value: F-value is derived from an ANOVA test (Analysis of Variance) and is used to compare the means of the distributions to examined if they are statistically different from each other. An F-value greater than 1 suggests a variability between the group means. Pr(>F): This is the p-value derived from the ANOVA test. A p-value less than 0.05 indicates a statistically significant difference between the group means. The smaller the p-value, the stronger the evidence against the null hypothesis (which would be that there is no difference between the group means). White dot: This indicates the mean of the data.

Journal: In Vivo

Article Title: FABP7: A Potential Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma

doi: 10.21873/invivo.13773

Figure Lengend Snippet: The violin plots of the correlation between FABP7 and the pathological stage of renal cell carcinoma (RCC) in each subtype. A) ccRCC; the level of FABP7 expression was closely associated with the advanced pathological stages of clear cell RCC (ccRCC). B and C) pRCC and chRCC; the expression of FABP7 was not statistically significant. The x-axis represents the FABP7 expression; the y-axis represents the pathological stages. F Value: F-value is derived from an ANOVA test (Analysis of Variance) and is used to compare the means of the distributions to examined if they are statistically different from each other. An F-value greater than 1 suggests a variability between the group means. Pr(>F): This is the p-value derived from the ANOVA test. A p-value less than 0.05 indicates a statistically significant difference between the group means. The smaller the p-value, the stronger the evidence against the null hypothesis (which would be that there is no difference between the group means). White dot: This indicates the mean of the data.

Article Snippet: The samples were stained with a FABP7 polyclonal antibody (dilution 1:100, Proteintech, Chicago, IL, USA).

Techniques: Expressing, Derivative Assay

The result of the Kaplan-Meier analysis of FABP7 expression in clear cell renal cell carcinoma (ccRCC) from the TCGA cohort: A) The overall survival analysis indicated no significant difference between the low and high expression of FABP7 in ccRCC patients; however, there was a trend toward significance [log-rank p=0.086; hazard ratio (HR)=1.3, p(HR)=0.087]. B) The disease-free survival analysis showed that high expression of FABP7 was associated with shortened survival in patients with ccRCC compared to those with low expression [log-rank p=0.008; HR=1.6; p(HR)=0.0087].

Journal: In Vivo

Article Title: FABP7: A Potential Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma

doi: 10.21873/invivo.13773

Figure Lengend Snippet: The result of the Kaplan-Meier analysis of FABP7 expression in clear cell renal cell carcinoma (ccRCC) from the TCGA cohort: A) The overall survival analysis indicated no significant difference between the low and high expression of FABP7 in ccRCC patients; however, there was a trend toward significance [log-rank p=0.086; hazard ratio (HR)=1.3, p(HR)=0.087]. B) The disease-free survival analysis showed that high expression of FABP7 was associated with shortened survival in patients with ccRCC compared to those with low expression [log-rank p=0.008; HR=1.6; p(HR)=0.0087].

Article Snippet: The samples were stained with a FABP7 polyclonal antibody (dilution 1:100, Proteintech, Chicago, IL, USA).

Techniques: Expressing